3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
3
Suspended
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
916
Sarcoma
354
Gastrointestinal
39
Thoracic
38
Dermatologic
31
Breast
29
Genitourinary
25
Gynecologic
22
Lymphoid
21
Head & Neck
20
Other hematologic neoplasm
15
Plasma cell
13
Other solid neoplasm
12
Endocrine
8
Myeloid
6
NET
2
Classical hematology
1
Conditions
Anemia, Refractory, with Excess of Blasts
167
Myelodysplastic Syndromes
159
Leukemia
155
Anemia
151
Leukemia, Myeloid, Acute
143
Neoplasms
124
Precursor Cell Lymphoblastic Leukemia-Lymphoma
114
Leukemia, Myelomonocytic, Chronic
111
Multiple Myeloma
90
Myeloproliferative Disorders
89
Leukemia, Lymphocytic, Chronic, B-Cell
87
Lymphoma, Non-Hodgkin
76
Hodgkin Disease
71
Lymphoma
66
Anemia, Refractory
64
Congenital Abnormalities
63
Venous Thromboembolism
62
Thrombocytopenia
59
Leukemia, Myeloid, Chronic-Phase
56
Blast Crisis
56
Leukemia, Myeloid, Accelerated Phase
52
Lymphoma, Follicular
51
Myelodysplastic-Myeloproliferative Diseases
48
Anemia, Aplastic
46
Primary Myelofibrosis
44
Lymphoma, Mantle-Cell
44
Neoplasms, Plasma Cell
43
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
41
Burkitt Lymphoma
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Glioblastoma
×
Classical hematology
×
Clear all
NCT02617745
2026-01-02
GLIOPLAK
Centre Henri Becquerel
Phase 2
Completed
244 enrolled